Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Ann Surg Oncol. 2014 Sep 17;22(3):834–842. doi: 10.1245/s10434-014-4042-6

Fig 1.

Fig 1

(A-D) Cumulative overall survival curves for patients with major and minor pathologic response overall (A) and stratified according to RAS mutational status (B). Cumulative overall survival curves for patients with optimal and suboptimal morphologic response overall (C) and stratified according to RAS mutational status (D).